CUV 0.00% $14.86 clinuvel pharmaceuticals limited

Have to agree, there may well be better opportunity out there....

  1. 682 Posts.
    lightbulb Created with Sketch. 192
    Have to agree, there may well be better opportunity out there. In terms of board and Management, at least at the board level there is change afoot. Hopefully they announce a significant addition. Hard to see PW is holding a lot of hand in a contract extension. His last 3 years have been a bit ordinary. Likely he will get the opportunity to extend but should be tied to revenue and SP growth. The plan is there, the execution takes time. Right now I actually get the price response to the half yearly and PW was notable absentee on the webinar. There has to be an adjustment to one price policy for EPP expansion but internally they are finding it a difficult one to traverse I guess. One excuse for not doing a buyback is how insurer's/regulators might see it as they are getting to much cash?? What's the difference if they look at their bank balance? SP could be reaching a point they consider a BB more seriously. Near term revenue could be addressed by a business purchase but ti seems to be tied to internal manufacturing aspirations? More selling I would understand but they do have some investor meetings coming up so could be a buy at some point in the near future?? GLTA
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
(20min delay)
Last
$14.86
Change
0.000(0.00%)
Mkt cap ! $744.5M
Open High Low Value Volume
$14.93 $15.07 $14.76 $684.2K 45.80K

Buyers (Bids)

No. Vol. Price($)
1 550 $14.86
 

Sellers (Offers)

Price($) Vol. No.
$14.99 219 1
View Market Depth
Last trade - 16.10pm 03/05/2024 (20 minute delay) ?
Last
$14.95
  Change
0.000 ( 0.36 %)
Open High Low Volume
$14.96 $15.07 $14.77 2565
Last updated 15.59pm 03/05/2024 ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.